• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组通过高剂量他克莫司改变对小鼠的免疫抑制作用。

Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice.

机构信息

Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Am J Transplant. 2018 Jul;18(7):1646-1656. doi: 10.1111/ajt.14661. Epub 2018 Feb 3.

DOI:10.1111/ajt.14661
PMID:29316256
Abstract

The alterations induced in gut microbiota by tacrolimus may affect immune function and organ transplantation. Mice were treated with high-dose tacrolimus for 14 days. The fecal microbiota were analyzed by pyrosequencing the 16S rRNA genes, and the effect on metabolism was predicted using the sequence data. The subgroups of T cells in the serum, gut-associated lymphoid tissue, and draining lymph nodes were determined by flow cytometry. Tacrolimus treatment significantly altered the relative abundance of Allobaculum, Bacteroides, and Lactobacillus and CD4 CD25 FoxP3 regulatory T cells in the colonic mucosa and the circulation. These were significantly increased after either tacrolimus treatment or treatment by fecal microbiota transfer from tacrolimus-treated donors. Further, treatment with low-dose tacrolimus plus fecal microbiota transfer from high-dose tacrolimus-altered mice increased skin allograft survival rate in a skin transplantation model. Thus, high-dose tacrolimus alters the compositions and taxa of the gut microbiota. Administration of these conditioned gut microbiota plus low-dose tacrolimus resulted in regulation of colonic and systemic immune responses and an increased allograft survival rate. This study demonstrated a new strategy for controlling allograft rejection by combining an immunosuppressive agent with gut microbiome transplantation.

摘要

环孢素诱导的肠道微生物群改变可能影响免疫功能和器官移植。用高剂量环孢素处理小鼠 14 天。通过焦磷酸测序 16S rRNA 基因分析粪便微生物群,并使用序列数据预测对代谢的影响。通过流式细胞术确定血清、肠道相关淋巴组织和引流淋巴结中的 T 细胞亚群。环孢素治疗显著改变了结肠黏膜和循环中 Allobaculum、拟杆菌和乳杆菌以及 CD4 CD25 FoxP3 调节性 T 细胞的相对丰度。在接受环孢素治疗或来自接受环孢素治疗的供体的粪便微生物群转移治疗后,这些都显著增加。此外,在皮肤移植模型中,低剂量环孢素加来自高剂量环孢素改变的小鼠的粪便微生物群转移治疗增加了皮肤移植物的存活率。因此,高剂量环孢素改变了肠道微生物群的组成和分类群。施用这些调理肠道微生物群加低剂量环孢素导致结肠和全身免疫反应的调节以及移植物存活率的增加。这项研究通过将免疫抑制剂与肠道微生物群移植相结合,为控制移植物排斥提供了一种新策略。

相似文献

1
Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice.肠道微生物组通过高剂量他克莫司改变对小鼠的免疫抑制作用。
Am J Transplant. 2018 Jul;18(7):1646-1656. doi: 10.1111/ajt.14661. Epub 2018 Feb 3.
2
Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8 T-Cells Through Altering the Gut Microbiota.小檗碱通过改变肠道微生物群下调记忆 CD8 T 细胞促进同种异体移植物免疫耐受的诱导。
Front Immunol. 2021 Feb 12;12:646831. doi: 10.3389/fimmu.2021.646831. eCollection 2021.
3
Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.肠道微生物代谢产物通过短链脂肪酸诱导调节性 T 细胞诱导供体特异性肾移植耐受。
J Am Soc Nephrol. 2020 Jul;31(7):1445-1461. doi: 10.1681/ASN.2019080852. Epub 2020 Jun 1.
4
Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.CD4(+)CD25(+)调节性 T 细胞联合小剂量西罗莫司而非钙调磷酸酶抑制剂治疗可保持调节性 T 细胞的抑制功能,并延长小鼠同种异体移植物的存活时间。
Int Immunopharmacol. 2009 May;9(5):553-63. doi: 10.1016/j.intimp.2009.01.033. Epub 2009 Feb 8.
5
Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.肠道微生物群依赖的先天免疫调节和淋巴结重构影响心脏移植物的结局。
JCI Insight. 2018 Oct 4;3(19):121045. doi: 10.1172/jci.insight.121045.
6
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.他克莫司的年龄依赖性代谢和免疫抑制作用。
Am J Transplant. 2017 May;17(5):1242-1254. doi: 10.1111/ajt.14087. Epub 2016 Nov 21.
7
The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.FTY720 处理导致皮肤移植排斥反应中 Treg 和 Th17 细胞失衡。
Clinics (Sao Paulo). 2012 Jul;67(7):805-13. doi: 10.6061/clinics/2012(07)17.
8
Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.睾丸内接种供体抗原通过诱导CD8 + CD122 +和CD4 + CD25 +调节性T细胞促进传统共刺激阻断诱导的皮肤同种异体移植接受。
Transplantation. 2016 Apr;100(4):763-71. doi: 10.1097/TP.0000000000001011.
9
Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.他克莫司诱导治疗后,西罗莫司对比霉酚酸酯在抗胸腺细胞球蛋白方案中促进调节性 T 细胞扩增,并抑制肾移植中 RORγt 和 T-bet 的表达。
Hum Immunol. 2019 Sep;80(9):739-747. doi: 10.1016/j.humimm.2018.12.010. Epub 2018 Dec 28.
10
Gut microbes contribute to variation in solid organ transplant outcomes in mice.肠道微生物有助于解释小鼠实体器官移植结局的个体差异。
Microbiome. 2018 May 25;6(1):96. doi: 10.1186/s40168-018-0474-8.

引用本文的文献

1
From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis.从实验台到临床:对他克莫司诱导的糖尿病和肠道微生物群失调的深入见解
Eur J Med Res. 2025 Aug 11;30(1):731. doi: 10.1186/s40001-025-03000-9.
2
Gut microbiota's role in heart failure.肠道微生物群在心力衰竭中的作用。
Heart Fail Rev. 2025 Jul 9. doi: 10.1007/s10741-025-10543-w.
3
Harnessing the microbiome to improve clinical outcomes for cancer, transplant, and immunocompromised patients in the intensive care unit (ICU).利用微生物群改善重症监护病房(ICU)中癌症、移植和免疫功能低下患者的临床结局。
Front Cell Infect Microbiol. 2025 Jun 12;15:1577108. doi: 10.3389/fcimb.2025.1577108. eCollection 2025.
4
Associations between the gut microbiota and the metabolism rate of tacrolimus in kidney transplant recipients during the early posttransplant period.肾移植受者移植后早期肠道微生物群与他克莫司代谢率之间的关联。
Arch Pharm Res. 2025 May 19. doi: 10.1007/s12272-025-01549-x.
5
Rapamycin immunomodulation utilizes time-dependent alterations of lymph node architecture, leukocyte trafficking, and gut microbiome.雷帕霉素免疫调节利用淋巴结结构、白细胞运输和肠道微生物群的时间依赖性改变。
JCI Insight. 2025 Apr 22;10(8). doi: 10.1172/jci.insight.186505.
6
Immunosuppressive drugs and diet interact to modify the gut microbiota and cardiovascular risk factors, and to trigger diabetes.免疫抑制药物与饮食相互作用,改变肠道微生物群和心血管危险因素,并引发糖尿病。
PLoS One. 2025 Mar 28;20(3):e0320438. doi: 10.1371/journal.pone.0320438. eCollection 2025.
7
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome.免疫抑制剂的不精确性:对代谢和微生物群的多向性影响
Clin Microbiol Rev. 2025 Jun 12;38(2):e0017824. doi: 10.1128/cmr.00178-24. Epub 2025 Mar 5.
8
Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model.在非人类灵长类动物缺血/再灌注模型中,通过免疫抑制进行心脏细胞治疗时对肠道微生物群的调节
NPJ Regen Med. 2025 Jan 15;10(1):2. doi: 10.1038/s41536-025-00390-6.
9
Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.肠道微生物失调及其在实体器官移植中的影响
Biomedicines. 2024 Dec 9;12(12):2792. doi: 10.3390/biomedicines12122792.
10
Changes in the gut microbiota and derived fecal metabolites may play a role in tacrolimus-induced diabetes in mice.肠道微生物群和粪便衍生代谢产物的变化可能在小鼠他克莫司诱导的糖尿病中起作用。
Future Microbiol. 2025 Feb;20(3):237-246. doi: 10.1080/17460913.2024.2444761. Epub 2024 Dec 22.